Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide

Fig. 1

Assessment of body weight in SPA4 peptide-treated CD-1 mice. The schedule of SPA4 peptide treatment and study design are illustrated in (a). Body weights were taken for each mouse after every 24 h. Results shown are from 11 to 15 mice per group (seven groups total) (b). No statistically significant difference was observed in body weights of mice over time and among different study groups (Two-way ANOVA followed by Tukey’s post hoc analysis)

Back to article page